Home Pharmaceuticals Antisense and RNAi Therapeutics Market Size, Top Share | Industry Report, 2033

Antisense and RNAi Therapeutics Market Size & Outlook, 2025-2033

Antisense and RNAi Therapeutics Market Size, Share & Trends Analysis Report By Technology (RNA Interference, siRNA, miRNA, Antisense RNA), By Application (Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Renal Diseases, Neurodegenerative Disorders, Genetic Disorders, Infectious Diseases, Others), By Route of Administration (Intravenous Route, Subcutaneous Route, Intrathecal Route, Pulmonary Delivery, Intraperitoneal Injection, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRPH56079DR
Last Updated : Jul, 2025
Pages : 110
Author : Mitiksha Koul
Format : PDF, Excel

Market Segmentation

  1. Antisense and RNAi Therapeutics Market, By Technology (2021-2033)
    1. RNA Interference
    2. siRNA
    3. miRNA
    4. Antisense RNA
  2. Antisense and RNAi Therapeutics Market, By Application (2021-2033)
    1. Oncology
    2. Cardiovascular Diseases (CVDs)
    3. Respiratory Disorders
    4. Renal Diseases
    5. Neurodegenerative Disorders
    6. Genetic Disorders
    7. Infectious Diseases
    8. Others
  3. Antisense and RNAi Therapeutics Market, By Route of Administration (2021-2033)
    1. Intravenous Route
    2. Subcutaneous Route
    3. Intrathecal Route
    4. Pulmonary Delivery
    5. Intraperitoneal Injection
    6. Others
    1. North America
      1. North America Antisense and RNAi Therapeutics Market, By Technology
        1. RNA Interference
          1. siRNA
            1. miRNA
              1. Antisense RNA
              2. North America Antisense and RNAi Therapeutics Market, By Application
                1. Oncology
                  1. Cardiovascular Diseases (CVDs)
                    1. Respiratory Disorders
                      1. Renal Diseases
                        1. Neurodegenerative Disorders
                          1. Genetic Disorders
                            1. Infectious Diseases
                              1. Others
                              2. North America Antisense and RNAi Therapeutics Market, By Route of Administration
                                1. Intravenous Route
                                  1. Subcutaneous Route
                                    1. Intrathecal Route
                                      1. Pulmonary Delivery
                                        1. Intraperitoneal Injection
                                          1. Others
                                          2. U.S.
                                            1. U.S. Antisense and RNAi Therapeutics Market, By Technology
                                              1. RNA Interference
                                                1. siRNA
                                                  1. miRNA
                                                    1. Antisense RNA
                                                    2. U.S. Antisense and RNAi Therapeutics Market, By Application
                                                      1. Oncology
                                                        1. Cardiovascular Diseases (CVDs)
                                                          1. Respiratory Disorders
                                                            1. Renal Diseases
                                                              1. Neurodegenerative Disorders
                                                                1. Genetic Disorders
                                                                  1. Infectious Diseases
                                                                    1. Others
                                                                    2. U.S. Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                      1. Intravenous Route
                                                                        1. Subcutaneous Route
                                                                          1. Intrathecal Route
                                                                            1. Pulmonary Delivery
                                                                              1. Intraperitoneal Injection
                                                                                1. Others
                                                                              2. Canada
                                                                            2. Europe
                                                                              1. Europe Antisense and RNAi Therapeutics Market, By Technology
                                                                                1. RNA Interference
                                                                                  1. siRNA
                                                                                    1. miRNA
                                                                                      1. Antisense RNA
                                                                                      2. Europe Antisense and RNAi Therapeutics Market, By Application
                                                                                        1. Oncology
                                                                                          1. Cardiovascular Diseases (CVDs)
                                                                                            1. Respiratory Disorders
                                                                                              1. Renal Diseases
                                                                                                1. Neurodegenerative Disorders
                                                                                                  1. Genetic Disorders
                                                                                                    1. Infectious Diseases
                                                                                                      1. Others
                                                                                                      2. Europe Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                        1. Intravenous Route
                                                                                                          1. Subcutaneous Route
                                                                                                            1. Intrathecal Route
                                                                                                              1. Pulmonary Delivery
                                                                                                                1. Intraperitoneal Injection
                                                                                                                  1. Others
                                                                                                                  2. U.K.
                                                                                                                    1. U.K. Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                      1. RNA Interference
                                                                                                                        1. siRNA
                                                                                                                          1. miRNA
                                                                                                                            1. Antisense RNA
                                                                                                                            2. U.K. Antisense and RNAi Therapeutics Market, By Application
                                                                                                                              1. Oncology
                                                                                                                                1. Cardiovascular Diseases (CVDs)
                                                                                                                                  1. Respiratory Disorders
                                                                                                                                    1. Renal Diseases
                                                                                                                                      1. Neurodegenerative Disorders
                                                                                                                                        1. Genetic Disorders
                                                                                                                                          1. Infectious Diseases
                                                                                                                                            1. Others
                                                                                                                                            2. U.K. Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                              1. Intravenous Route
                                                                                                                                                1. Subcutaneous Route
                                                                                                                                                  1. Intrathecal Route
                                                                                                                                                    1. Pulmonary Delivery
                                                                                                                                                      1. Intraperitoneal Injection
                                                                                                                                                        1. Others
                                                                                                                                                      2. Germany
                                                                                                                                                      3. France
                                                                                                                                                      4. Spain
                                                                                                                                                      5. Italy
                                                                                                                                                      6. Russia
                                                                                                                                                      7. Nordic
                                                                                                                                                      8. Benelux
                                                                                                                                                      9. Rest of Europe
                                                                                                                                                    2. APAC
                                                                                                                                                      1. APAC Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                                                        1. RNA Interference
                                                                                                                                                          1. siRNA
                                                                                                                                                            1. miRNA
                                                                                                                                                              1. Antisense RNA
                                                                                                                                                              2. APAC Antisense and RNAi Therapeutics Market, By Application
                                                                                                                                                                1. Oncology
                                                                                                                                                                  1. Cardiovascular Diseases (CVDs)
                                                                                                                                                                    1. Respiratory Disorders
                                                                                                                                                                      1. Renal Diseases
                                                                                                                                                                        1. Neurodegenerative Disorders
                                                                                                                                                                          1. Genetic Disorders
                                                                                                                                                                            1. Infectious Diseases
                                                                                                                                                                              1. Others
                                                                                                                                                                              2. APAC Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                                                                1. Intravenous Route
                                                                                                                                                                                  1. Subcutaneous Route
                                                                                                                                                                                    1. Intrathecal Route
                                                                                                                                                                                      1. Pulmonary Delivery
                                                                                                                                                                                        1. Intraperitoneal Injection
                                                                                                                                                                                          1. Others
                                                                                                                                                                                          2. China
                                                                                                                                                                                            1. China Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                                                                                              1. RNA Interference
                                                                                                                                                                                                1. siRNA
                                                                                                                                                                                                  1. miRNA
                                                                                                                                                                                                    1. Antisense RNA
                                                                                                                                                                                                    2. China Antisense and RNAi Therapeutics Market, By Application
                                                                                                                                                                                                      1. Oncology
                                                                                                                                                                                                        1. Cardiovascular Diseases (CVDs)
                                                                                                                                                                                                          1. Respiratory Disorders
                                                                                                                                                                                                            1. Renal Diseases
                                                                                                                                                                                                              1. Neurodegenerative Disorders
                                                                                                                                                                                                                1. Genetic Disorders
                                                                                                                                                                                                                  1. Infectious Diseases
                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                    2. China Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                                                                                                      1. Intravenous Route
                                                                                                                                                                                                                        1. Subcutaneous Route
                                                                                                                                                                                                                          1. Intrathecal Route
                                                                                                                                                                                                                            1. Pulmonary Delivery
                                                                                                                                                                                                                              1. Intraperitoneal Injection
                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                              2. Korea
                                                                                                                                                                                                                              3. Japan
                                                                                                                                                                                                                              4. India
                                                                                                                                                                                                                              5. Australia
                                                                                                                                                                                                                              6. Singapore
                                                                                                                                                                                                                              7. Taiwan
                                                                                                                                                                                                                              8. South East Asia
                                                                                                                                                                                                                              9. Rest of Asia-Pacific
                                                                                                                                                                                                                            2. Middle East and Africa
                                                                                                                                                                                                                              1. Middle East and Africa Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                                                                                                                                1. RNA Interference
                                                                                                                                                                                                                                  1. siRNA
                                                                                                                                                                                                                                    1. miRNA
                                                                                                                                                                                                                                      1. Antisense RNA
                                                                                                                                                                                                                                      2. Middle East and Africa Antisense and RNAi Therapeutics Market, By Application
                                                                                                                                                                                                                                        1. Oncology
                                                                                                                                                                                                                                          1. Cardiovascular Diseases (CVDs)
                                                                                                                                                                                                                                            1. Respiratory Disorders
                                                                                                                                                                                                                                              1. Renal Diseases
                                                                                                                                                                                                                                                1. Neurodegenerative Disorders
                                                                                                                                                                                                                                                  1. Genetic Disorders
                                                                                                                                                                                                                                                    1. Infectious Diseases
                                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                                      2. Middle East and Africa Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                                                                                                                                        1. Intravenous Route
                                                                                                                                                                                                                                                          1. Subcutaneous Route
                                                                                                                                                                                                                                                            1. Intrathecal Route
                                                                                                                                                                                                                                                              1. Pulmonary Delivery
                                                                                                                                                                                                                                                                1. Intraperitoneal Injection
                                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                                  2. UAE
                                                                                                                                                                                                                                                                    1. UAE Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                                                                                                                                                                      1. RNA Interference
                                                                                                                                                                                                                                                                        1. siRNA
                                                                                                                                                                                                                                                                          1. miRNA
                                                                                                                                                                                                                                                                            1. Antisense RNA
                                                                                                                                                                                                                                                                            2. UAE Antisense and RNAi Therapeutics Market, By Application
                                                                                                                                                                                                                                                                              1. Oncology
                                                                                                                                                                                                                                                                                1. Cardiovascular Diseases (CVDs)
                                                                                                                                                                                                                                                                                  1. Respiratory Disorders
                                                                                                                                                                                                                                                                                    1. Renal Diseases
                                                                                                                                                                                                                                                                                      1. Neurodegenerative Disorders
                                                                                                                                                                                                                                                                                        1. Genetic Disorders
                                                                                                                                                                                                                                                                                          1. Infectious Diseases
                                                                                                                                                                                                                                                                                            1. Others
                                                                                                                                                                                                                                                                                            2. UAE Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                                                                                                                                                                              1. Intravenous Route
                                                                                                                                                                                                                                                                                                1. Subcutaneous Route
                                                                                                                                                                                                                                                                                                  1. Intrathecal Route
                                                                                                                                                                                                                                                                                                    1. Pulmonary Delivery
                                                                                                                                                                                                                                                                                                      1. Intraperitoneal Injection
                                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                                                                      1. LATAM Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                                                                                                                                                                                                        1. RNA Interference
                                                                                                                                                                                                                                                                                                          1. siRNA
                                                                                                                                                                                                                                                                                                            1. miRNA
                                                                                                                                                                                                                                                                                                              1. Antisense RNA
                                                                                                                                                                                                                                                                                                              2. LATAM Antisense and RNAi Therapeutics Market, By Application
                                                                                                                                                                                                                                                                                                                1. Oncology
                                                                                                                                                                                                                                                                                                                  1. Cardiovascular Diseases (CVDs)
                                                                                                                                                                                                                                                                                                                    1. Respiratory Disorders
                                                                                                                                                                                                                                                                                                                      1. Renal Diseases
                                                                                                                                                                                                                                                                                                                        1. Neurodegenerative Disorders
                                                                                                                                                                                                                                                                                                                          1. Genetic Disorders
                                                                                                                                                                                                                                                                                                                            1. Infectious Diseases
                                                                                                                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                                                                                                                              2. LATAM Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                                                                                                                                                                                                                1. Intravenous Route
                                                                                                                                                                                                                                                                                                                                  1. Subcutaneous Route
                                                                                                                                                                                                                                                                                                                                    1. Intrathecal Route
                                                                                                                                                                                                                                                                                                                                      1. Pulmonary Delivery
                                                                                                                                                                                                                                                                                                                                        1. Intraperitoneal Injection
                                                                                                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                                                                                                          2. Brazil
                                                                                                                                                                                                                                                                                                                                            1. Brazil Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                                                                                                                                                                                                                                              1. RNA Interference
                                                                                                                                                                                                                                                                                                                                                1. siRNA
                                                                                                                                                                                                                                                                                                                                                  1. miRNA
                                                                                                                                                                                                                                                                                                                                                    1. Antisense RNA
                                                                                                                                                                                                                                                                                                                                                    2. Brazil Antisense and RNAi Therapeutics Market, By Application
                                                                                                                                                                                                                                                                                                                                                      1. Oncology
                                                                                                                                                                                                                                                                                                                                                        1. Cardiovascular Diseases (CVDs)
                                                                                                                                                                                                                                                                                                                                                          1. Respiratory Disorders
                                                                                                                                                                                                                                                                                                                                                            1. Renal Diseases
                                                                                                                                                                                                                                                                                                                                                              1. Neurodegenerative Disorders
                                                                                                                                                                                                                                                                                                                                                                1. Genetic Disorders
                                                                                                                                                                                                                                                                                                                                                                  1. Infectious Diseases
                                                                                                                                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                                                                                                                                    2. Brazil Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                                                                                                                                                                                                                                                      1. Intravenous Route
                                                                                                                                                                                                                                                                                                                                                                        1. Subcutaneous Route
                                                                                                                                                                                                                                                                                                                                                                          1. Intrathecal Route
                                                                                                                                                                                                                                                                                                                                                                            1. Pulmonary Delivery
                                                                                                                                                                                                                                                                                                                                                                              1. Intraperitoneal Injection
                                                                                                                                                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                                                                                                                                              2. Mexico
                                                                                                                                                                                                                                                                                                                                                                              3. Argentina
                                                                                                                                                                                                                                                                                                                                                                              4. Chile
                                                                                                                                                                                                                                                                                                                                                                              5. Colombia
                                                                                                                                                                                                                                                                                                                                                                              6. Rest of LATAM

                                                                                                                                                                                                                                                                                                                                                                          Available for purchase with detailed segment data, forecasts, and regional insights.

                                                                                                                                                                                                                                                                                                                                                                          Get This Report

                                                                                                                                                                                                                                                                                                                                                                          Download Free Sample

                                                                                                                                                                                                                                                                                                                                                                          Note: Please ensure you provide an active email address as we will be sending sample details via email.
                                                                                                                                                                                                                                                                                                                                                                          The button will be active once the above form is filled

                                                                                                                                                                                                                                                                                                                                                                          Our Clients:

                                                                                                                                                                                                                                                                                                                                                                          LG Electronics
                                                                                                                                                                                                                                                                                                                                                                          AMCAD Engineering
                                                                                                                                                                                                                                                                                                                                                                          KOBE STEEL LTD.
                                                                                                                                                                                                                                                                                                                                                                          Hindustan National Glass & Industries Limited
                                                                                                                                                                                                                                                                                                                                                                          Voith Group
                                                                                                                                                                                                                                                                                                                                                                          International Paper
                                                                                                                                                                                                                                                                                                                                                                          Hansol Paper
                                                                                                                                                                                                                                                                                                                                                                          Whirlpool Corporation
                                                                                                                                                                                                                                                                                                                                                                          Sony
                                                                                                                                                                                                                                                                                                                                                                          Samsung Electronics
                                                                                                                                                                                                                                                                                                                                                                          Qualcomm
                                                                                                                                                                                                                                                                                                                                                                          Google
                                                                                                                                                                                                                                                                                                                                                                          Fiserv
                                                                                                                                                                                                                                                                                                                                                                          Veto-Pharma
                                                                                                                                                                                                                                                                                                                                                                          Nippon Becton Dickinson
                                                                                                                                                                                                                                                                                                                                                                          Merck
                                                                                                                                                                                                                                                                                                                                                                          Argon Medical Devices
                                                                                                                                                                                                                                                                                                                                                                          Abbott
                                                                                                                                                                                                                                                                                                                                                                          Ajinomoto
                                                                                                                                                                                                                                                                                                                                                                          Denon
                                                                                                                                                                                                                                                                                                                                                                          Doosan
                                                                                                                                                                                                                                                                                                                                                                          Meiji Seika Kaisha Ltd
                                                                                                                                                                                                                                                                                                                                                                          LG Chemicals
                                                                                                                                                                                                                                                                                                                                                                          LCY chemical group
                                                                                                                                                                                                                                                                                                                                                                          Bayer
                                                                                                                                                                                                                                                                                                                                                                          Airrane
                                                                                                                                                                                                                                                                                                                                                                          BASF
                                                                                                                                                                                                                                                                                                                                                                          Toyota Industries
                                                                                                                                                                                                                                                                                                                                                                          Nissan Motors
                                                                                                                                                                                                                                                                                                                                                                          Neenah
                                                                                                                                                                                                                                                                                                                                                                          Mitsubishi
                                                                                                                                                                                                                                                                                                                                                                          Hyundai Motor Company

                                                                                                                                                                                                                                                                                                                                                                          We are featured on :

                                                                                                                                                                                                                                                                                                                                                                          Address:
                                                                                                                                                                                                                                                                                                                                                                          Office 515 A, Amanora Chambers,
                                                                                                                                                                                                                                                                                                                                                                          Amanora Park Town, Hadapsar,
                                                                                                                                                                                                                                                                                                                                                                          Pune 411028, Maharashtra, India.
                                                                                                                                                                                                                                                                                                                                                                          Contact Us:
                                                                                                                                                                                                                                                                                                                                                                          +1 646 905 0080 (U.S.)
                                                                                                                                                                                                                                                                                                                                                                          +91 8087085354 (India)
                                                                                                                                                                                                                                                                                                                                                                          +44 203 695 0070 (U.K.)

                                                                                                                                                                                                                                                                                                                                                                          sales@straitsresearch.com

                                                                                                                                                                                                                                                                                                                                                                          Quick Links
                                                                                                                                                                                                                                                                                                                                                                          Help
                                                                                                                                                                                                                                                                                                                                                                          Verified. Protected. Secure.
                                                                                                                                                                                                                                                                                                                                                                          DMCA.com Protection Status
                                                                                                                                                                                                                                                                                                                                                                          Secure Payments:
                                                                                                                                                                                                                                                                                                                                                                          Follow Us:
                                                                                                                                                                                                                                                                                                                                                                          www.straitsresearch.com © Copyright . All rights Reserved.